Cargando…
Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade
BACKGROUND: Changes in the levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) observed during periodontal disease were linked with vascular manifestations. Recent studies showed that the beta-blocker propranolol reduces the pathological parameters associate...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906902/ https://www.ncbi.nlm.nih.gov/pubmed/31849395 http://dx.doi.org/10.4103/jisp.jisp_77_19 |
_version_ | 1783478445861240832 |
---|---|
author | Rodrigues, Wellington Francisco Miguel, Camila Botelho Lazo-Chica, Javier Emilio Trindade da Silva, Carlos Antônio Vieira, Carlos Ueira Clemente-Napimoga, Juliana Trindade Freire Oliveira, Carlo José Napimoga, Marcelo Henrique |
author_facet | Rodrigues, Wellington Francisco Miguel, Camila Botelho Lazo-Chica, Javier Emilio Trindade da Silva, Carlos Antônio Vieira, Carlos Ueira Clemente-Napimoga, Juliana Trindade Freire Oliveira, Carlo José Napimoga, Marcelo Henrique |
author_sort | Rodrigues, Wellington Francisco |
collection | PubMed |
description | BACKGROUND: Changes in the levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) observed during periodontal disease were linked with vascular manifestations. Recent studies showed that the beta-blocker propranolol reduces the pathological parameters associated with certain molecules at sites of bone injury. Hence, in this study, we evaluated the activity of propranolol on hematological parameters and systemic concentrations of inflammatory proteins in a model of experimental periodontitis. MATERIALS AND METHODS: Periodontal disease was induced in rats. After euthanasia, the number of inflammatory cells in each rat was quantified using histopathological assays. In addition, hematological parameters were quantitated using automated analysers, cytokine levels were determined using an enzyme-linked immunosorbent assay, and CRP levels were determined using a high-sensitivity immunoturbidimetric assay. RESULTS: Low doses of propranolol suppressed the systemic production of CRP, TNF-α, and IL-6; however, the hematological parameters were not affected. CONCLUSIONS: β-adrenergic activation indirectly contributes to the pattern of systemic inflammatory molecules observed in periodontal disease. These molecules may initiate cardiovascular diseases as a consequence of periodontitis. |
format | Online Article Text |
id | pubmed-6906902 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-69069022019-12-17 Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade Rodrigues, Wellington Francisco Miguel, Camila Botelho Lazo-Chica, Javier Emilio Trindade da Silva, Carlos Antônio Vieira, Carlos Ueira Clemente-Napimoga, Juliana Trindade Freire Oliveira, Carlo José Napimoga, Marcelo Henrique J Indian Soc Periodontol Original Article BACKGROUND: Changes in the levels of C-reactive protein (CRP), tumor necrosis factor α (TNF-α), and interleukin 6 (IL-6) observed during periodontal disease were linked with vascular manifestations. Recent studies showed that the beta-blocker propranolol reduces the pathological parameters associated with certain molecules at sites of bone injury. Hence, in this study, we evaluated the activity of propranolol on hematological parameters and systemic concentrations of inflammatory proteins in a model of experimental periodontitis. MATERIALS AND METHODS: Periodontal disease was induced in rats. After euthanasia, the number of inflammatory cells in each rat was quantified using histopathological assays. In addition, hematological parameters were quantitated using automated analysers, cytokine levels were determined using an enzyme-linked immunosorbent assay, and CRP levels were determined using a high-sensitivity immunoturbidimetric assay. RESULTS: Low doses of propranolol suppressed the systemic production of CRP, TNF-α, and IL-6; however, the hematological parameters were not affected. CONCLUSIONS: β-adrenergic activation indirectly contributes to the pattern of systemic inflammatory molecules observed in periodontal disease. These molecules may initiate cardiovascular diseases as a consequence of periodontitis. Wolters Kluwer - Medknow 2019 /pmc/articles/PMC6906902/ /pubmed/31849395 http://dx.doi.org/10.4103/jisp.jisp_77_19 Text en Copyright: © 2019 Indian Society of Periodontology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Rodrigues, Wellington Francisco Miguel, Camila Botelho Lazo-Chica, Javier Emilio Trindade da Silva, Carlos Antônio Vieira, Carlos Ueira Clemente-Napimoga, Juliana Trindade Freire Oliveira, Carlo José Napimoga, Marcelo Henrique Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade |
title | Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade |
title_full | Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade |
title_fullStr | Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade |
title_full_unstemmed | Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade |
title_short | Interleukin-6, tumor necrosis factor-α, C-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade |
title_sort | interleukin-6, tumor necrosis factor-α, c-reactive protein, and hematological parameters in experimental periodontal disease after β-adrenergic blockade |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906902/ https://www.ncbi.nlm.nih.gov/pubmed/31849395 http://dx.doi.org/10.4103/jisp.jisp_77_19 |
work_keys_str_mv | AT rodrigueswellingtonfrancisco interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade AT miguelcamilabotelho interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade AT lazochicajavieremilio interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade AT trindadedasilvacarlosantonio interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade AT vieiracarlosueira interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade AT clementenapimogajulianatrindade interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade AT freireoliveiracarlojose interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade AT napimogamarcelohenrique interleukin6tumornecrosisfactoracreactiveproteinandhematologicalparametersinexperimentalperiodontaldiseaseafterbadrenergicblockade |